Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Hudson

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Medicinal Chemistry|August 30, 2016
Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic ActivityCarlos M G Azevedo, Kenneth R Watterson, Ed T Wargent, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2021
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative diseaseMiriam Scarpa, Colin Molloy, Laura Jenkins, et al.
ACS Medicinal Chemistry Letters|May 21, 2013
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 DiabetesElisabeth Christiansen, Steffen V F Hansen, Christian Urban, et al.
The British Journal of Nutrition|April 29, 2015
Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseasesElisabeth Christiansen, Kenneth R Watterson, Claire J Stocker, et al.
Journal of Medicinal Chemistry|January 9, 2013
Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailabilityElisabeth Christiansen, Maria E Due-Hansen, Christian Urban, et al.
Journal of Medicinal Chemistry|March 2, 2016
Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo EfficacySteffen V F Hansen, Elisabeth Christiansen, Christian Urban, et al.
Nature Chemical Biology|August 5, 2025
Intracrine FFA4 signaling controls lipolysis at lipid dropletsShannon L O'Brien, Emma Tripp, Natasja Barki, et al.
The Journal of Biological Chemistry|April 19, 2014
Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J miceEven Fjære, Ulrike L Aune, Kristin Røen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2017
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistanceJulia M Houthuijzen, Ilse Oosterom, Brian D Hudson, et al.
Cell|November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's diseaseAlastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Medicinal Chemistry|August 30, 2016
Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic ActivityCarlos M G Azevedo, Kenneth R Watterson, Ed T Wargent, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2021
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative diseaseMiriam Scarpa, Colin Molloy, Laura Jenkins, et al.
ACS Medicinal Chemistry Letters|May 21, 2013
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 DiabetesElisabeth Christiansen, Steffen V F Hansen, Christian Urban, et al.
The British Journal of Nutrition|April 29, 2015
Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseasesElisabeth Christiansen, Kenneth R Watterson, Claire J Stocker, et al.
Journal of Medicinal Chemistry|January 9, 2013
Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailabilityElisabeth Christiansen, Maria E Due-Hansen, Christian Urban, et al.
Journal of Medicinal Chemistry|March 2, 2016
Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo EfficacySteffen V F Hansen, Elisabeth Christiansen, Christian Urban, et al.
Nature Chemical Biology|August 5, 2025
Intracrine FFA4 signaling controls lipolysis at lipid dropletsShannon L O'Brien, Emma Tripp, Natasja Barki, et al.
The Journal of Biological Chemistry|April 19, 2014
Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J miceEven Fjære, Ulrike L Aune, Kristin Røen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2017
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistanceJulia M Houthuijzen, Ilse Oosterom, Brian D Hudson, et al.
Cell|November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's diseaseAlastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Pageof 6